Literature DB >> 32748220

Inhibition of Lnc-OC1 Induced Cell Apoptosis and Decreased Cell Viability by Releasing miR-34a and Inhibiting PD-L1 in Endometrial Carcinoma.

Yun Liu1, Yue Chang2, Yi-Xuan Cai2.   

Abstract

Now, there is a growing awareness of the role to long non-coding RNAs (lncRNAs) in tumorigenesis and progression of a variety of malignancies including endometrial carcinoma (EC). Here, we explored the potential molecular mechanism of Lnc-OC1, a novel lncRNA, in the development of EC. Our results suggested that Lnc-OC1 was significantly upregulated in EC tissues comparing with normal tissues. Besides, Lnc-OC1 was higher expressed in the more advanced stage of EC. Therefore, Lnc-OC1 might be a crucial regulator in the progress of EC. Moreover, knockdown of Lnc-OC1 leaded to an inhibition of cell viability and a raise of cell apoptosis. In addition, Lnc-OC1 could sponge miR-34a and thus decrease its expression. miR-34a was proved to be a tumor suppressor in different malignance, hence downregulating Lnc-OC1 helped to alleviate EC by releasing miR-34a. Furthermore, rescue experiments significantly indicated that knockdown of Lnc-OC1 inhibited cell growth through repressing PD-L1 expression at least partially. Concisely, our results proved that Lnc-OC1/miR-34a/PD-L1 axis might serve as a therapeutic target of EC.

Entities:  

Keywords:  Endometrial carcinoma; Lnc-OC1; PD-L1; miR-34a

Mesh:

Substances:

Year:  2020        PMID: 32748220     DOI: 10.1007/s43032-020-00202-w

Source DB:  PubMed          Journal:  Reprod Sci        ISSN: 1933-7191            Impact factor:   3.060


  4 in total

Review 1.  Mechanisms regulating PD-L1 expression in cancers and associated opportunities for novel small-molecule therapeutics.

Authors:  Hirohito Yamaguchi; Jung-Mao Hsu; Wen-Hao Yang; Mien-Chie Hung
Journal:  Nat Rev Clin Oncol       Date:  2022-02-07       Impact factor: 66.675

2.  Application of Pelvic Magnetic Resonance Imaging Scan Combined with Serum Pyruvate Kinase Isozyme M2, Neutrophil Gelatinase-Associated Lipocalin, and Soluble Leptin Receptor Detection in Diagnosing Endometrial Carcinoma.

Authors:  Shizhong Su; Liping Yin
Journal:  Contrast Media Mol Imaging       Date:  2022-05-21       Impact factor: 3.009

Review 3.  The role of lncRNAs and circRNAs in the PD-1/PD-L1 pathway in cancer immunotherapy.

Authors:  Wenxiao Jiang; Shuya Pan; Xin Chen; Zhi-Wei Wang; Xueqiong Zhu
Journal:  Mol Cancer       Date:  2021-09-08       Impact factor: 27.401

Review 4.  Endometrial Cancer Stem Cells: Where Do We Stand and Where Should We Go?

Authors:  Constanze Banz-Jansen; Laureen P Helweg; Barbara Kaltschmidt
Journal:  Int J Mol Sci       Date:  2022-03-21       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.